Structure-Based Design of Covalent SARS-CoV‑2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants
基于结构的共价SARS-CoV-2主蛋白酶抑制剂设计，靶向耐尼马替利韦的E166突变体
期刊:JACS Au
影响因子:8.7
doi:10.1021/jacsau.5c01178
Cai, Zhengjun; Kohaal, Navita; Georgiou, Kyriakos; Liang, Xueying; Chi, Xiang; Tan, Haozhou; Tan, Bin; Li, Kan; Fan, Guangjin; Lambrinidis, George; Kolocouris, Antonios; Deng, Xufang; Chen, Yu; Wang, Jun
